Comprehensive Adult Immunization Schedule
Stay Informed and Protected: Your Guide to Essential Vaccinations for Adults
Your Guide to Essential Adult Vaccines for Lifelong Health and Protection.
Recommended vaccination for adults who meet age requirement, lack documentation of vaccination, or lack evidence of immunity
Recommended vaccination for adults with an additional risk factor or another indication
Recommended vaccination based on shared clinical decision-making
Recommended vaccination based on shared clinical decision-making
| Vaccine | 19-26 years | 27-49 years | 50-64 years | ≥65 years | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COVID-19 
|
1 or more doses of updated (2023–2024 Formula) vaccine | ||||||||||||
| Influenza inactivated (IIV4) or
Influenza recombinant (RIV4)
|
1 dose annually | ||||||||||||
| Or
Influenza live attenuated
(LAIV4) |
Or 1 dose annually | ||||||||||||
| Respiratory Syncytial Virus
(RSV) |
Seasonal administration during pregnancy | ≥60 years | |||||||||||
| Tetanus, diphtheria, pertussis
(Tdap or Td) |
1 dose Tdap each pregnancy; 1 dose Td/Tdap for wound management | ||||||||||||
| 1 dose Tdap, then Td or Tdap booster every 10 years | |||||||||||||
| Measles, mumps, rubella
(MMR) |
1 or 2 doses depending on indication
(if born in 1957 or later) |
For healthcare personnel,
|
|||||||||||
| Varicella
(VAR) |
2 doses
(if born in 1980 or later) |
2 doses | |||||||||||
| Zoster recombinant
(RZV) |
2 doses for immunocompromising conditions | 2 doses | |||||||||||
| Human papillomavirus
(HPV) |
2 or 3 doses depending on age at initial vaccination or condition | 27 through 45 years | |||||||||||
| Pneumococcal
(PCV15, PCV20, PPSV23) |
|||||||||||||
| Hepatitis A
(HepA) |
2, 3, or 4 doses depending on vaccine | ||||||||||||
| Hepatitis B
(HepB) |
2, 3, or 4 doses depending on vaccine or | condition | |||||||||||
| Vaccine | Recommended age of vaccination |
|---|---|
| COVID-19 | 1 or more doses of updated (2023–2024 Formula) vaccine |
| Influenza inactivated (IIV4) or Influenza recombinant (RIV4) |
Yearly |
|
Or Influenza live attenuated (LAIV4) |
Yearly |
| Respiratory Syncytial Virus (RSV) | 60 years or older who are at increased risk for severe RSV disease |
| Tetanus, diphtheria, pertussis (Tdap or Td) | Tdap once as an adult Td every 10 years |
| Measles, mumps, rubella (MMR) | One or two doses (unless immunized previously, known to have been previously infected or born prior to 1957) |
| Varicella (VAR) |
Two doses (unless had documented disease or immunized as a child or adolescent) |
| Zoster recombinant (RZV) |
One dose after 60 years of age |
| Human papillomavirus (HPV) |
Three doses before 26 years of age (unless already immunized as an adolescent) |
| Pneumococcal (PCV15, PCV20, PPSV23) |
All people over 65 years of age People in special high-risk groups and who have certain chronic illnesses should receive both of the two different pneumococcal vaccines as soon as possible |
| Hepatitis A (HepA) |
Two doses in certain patients who are high risk (unless immunized previously) |
| Hepatitis B (HepB) |
Three doses in certain patients who are high risk (unless immunized previously) |
| Haemophilus influenza type b (Hib) | One to three doses in certain patients who are high risk (unless immunized previously) |
